Back to Search Start Over

Well-Being of Pediatric Hematology Oncology Providers and Staff During the COVID-19 Pandemic in the New York and New Jersey Epicenter.

Authors :
Moerdler S
Steinberg DM
Jin Z
Cole PD
Levy AS
Rosenthal SL
Source :
JCO oncology practice [JCO Oncol Pract] 2021 Jul; Vol. 17 (7), pp. e925-e935. Date of Electronic Publication: 2021 Feb 17.
Publication Year :
2021

Abstract

Purpose: The COVID-19 pandemic has significantly affected the well-being of healthcare workers to varying degrees. The aim of the current study was to investigate how the pandemic has affected the burnout, stress, and emotional well-being of pediatric hematology oncology (PHO) providers and staff in the New York and New Jersey epicenter.<br />Methods: The study was conducted in June 2020 during the pandemic through an electronic survey. The survey contained questions surrounding demographics, pandemic experiences, and validated burnout, stress, and emotional well-being measures.<br />Results: Two hundred fifty-two PHO providers and staff responded to the survey. Overall, half of the participants reported high levels of burnout, average stress scores were in the mild-moderate range, and the majority scored in the none-to-mild symptomatology range for their well-being. Self-reported burnout levels before the pandemic and geographic work location were statistically significant risk factors for all outcomes. Additional predictors for some outcomes included hospital role, lack of trust in leadership, and deployment. The majority of participants (87.0%) reported that their hospitals had made mental health resources related to COVID-19 available to them but only 8.4% reported having used them.<br />Conclusion: PHO providers and staff in the NYC/NJ area are experiencing a range of emotional experiences during the COVID-19 pandemic, but the majority are not using current resources. With the continuation of the pandemic, we must continue efforts to improve provider and staff distress to mitigate the degree of potential negative short-term and long-term impact.<br />Competing Interests: Adam S. LevyConsulting or Advisory Role: AstraZenecaNo other potential conflicts of interest were reported.

Details

Language :
English
ISSN :
2688-1535
Volume :
17
Issue :
7
Database :
MEDLINE
Journal :
JCO oncology practice
Publication Type :
Academic Journal
Accession number :
33596094
Full Text :
https://doi.org/10.1200/OP.20.00882